Treatment of respiratory tract infections with ciprofloxacin
- PMID: 3804902
- DOI: 10.1093/jac/18.supplement_d.139
Treatment of respiratory tract infections with ciprofloxacin
Abstract
The efficacy and safety of ciprofloxacin in an oral dose of 750 mg twice daily, in the treatment of respiratory infections was studied in 129 patients. Ciprofloxacin showed broad in-vitro antibacterial activity and was highly effective in both Gram-negative and Gram-positive infections with a clinical cure rate of 96%. The major side effect was an interaction with theophylline particularly in the elderly patients.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
